Results 191 to 200 of about 4,690 (200)

Imipenem monohydrate/cilastatin sodium/relebactam monohydrate, pretomanid, and elexacaftor/tezacaftor/ivacaftor

Journal of the American Pharmacists Association, 2020
Daniel A, Hussar, Elias B, Chahine
openaire   +2 more sources

P344 Weight and wellbeing on elexacaftor/tezacaftor/ivacaftor

Journal of Cystic Fibrosis
L. Harneshaug, K. Westcott, A. Gurney, C. Van-Zwaneberg, C. Echevarria, S.J. Bourke   +5 more
openaire   +1 more source

P157 Elexacaftor/tezacaftor/ivacaftor: eligibility, tolerability and indications

Journal of Cystic Fibrosis
N. Molloy, A. Anderson, S. Doe, A. Duffy, C. Echevarria, S. Bourke   +5 more
openaire   +1 more source

Elexacaftor/tezacaftor/ivacaftor (Trikafta) for cystic fibrosis.

The Medical letter on drugs and therapeutics, 2020
openaire   +1 more source

Crushing Elexacaftor/Tezacaftor/Ivacaftor Oral Granules for Gastrostomy Tube Administration

Pediatric Pulmonology
Alexander S. Kim, Elizabeth Autry
openaire   +2 more sources

494 Pharmacokinetics of elexacaftor/tezacaftor/ivacaftor with concomitant rifabutin

Journal of Cystic Fibrosis
M. Sanders, E. Hong, P. Chung, A. Rao, P. Beringer   +4 more
openaire   +1 more source

Possible Drug Interaction Between Elexacaftor-Tezacaftor-Ivacaftor and Repaglinide

Canadian Journal of Diabetes
MIRNA GERGES, MEREDITH CHIASSON, CARLY NICHOLS, NANCY MORRISON, SARAH SUTHERLAND, BARNA DE   +5 more
openaire   +1 more source

Nontuberculous mycobacterial pulmonary infections in the era of elexacaftor-tezacaftor-ivacaftor

Journal of Cystic Fibrosis
Christina M. Mingora, Lindsay J. Caverly
openaire   +2 more sources

Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine
Sarah J. Morgan, David P. Nichols, Windy Ni, Gina Hong, Stephen J. Salipante, George M. Solomon, Steven M. Rowe, John P. Clancy, Robert A. Cramer, Pradeep K. Singh   +9 more
openaire   +2 more sources

Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis

Lancet, The
exaly